摘要
同源框(HOX)反转录物的RNA(HOTAIR),长核保留非编码RNA(lncRNA),在各种人类癌症过度表达。越来越多的证据表明,通过影响细胞周期进展,HOTAIR起着癌症引发和进展,细胞凋亡和侵袭的至关重要的作用。然而,无论是HOTAIR作为治疗潜力的头颈部鳞状细胞癌的作用机制(头颈部鳞癌)和目标目前还不清楚。因此,我们采用了一种HOTAIR特异siRNA耗尽其在HNSCC细胞系和舌鳞癌表达。流式细胞术(FCM)分析表明,HOTAIR耗尽诱发体外肿瘤细胞凋亡。JC-1探针检查表明线粒体膜电位是得到HOTAIR堵塞显著改变。线粒体钙吸收1(MICU1)依赖的细胞死亡诱导HOTAIR枯竭。蛋白质表达分析表明,线粒体相关的细胞死亡途径(BCL-2,BAX和细胞凋亡蛋白酶-3,裂解的细胞凋亡蛋白酶-3,细胞色素C)参与HOTAIR依赖的细胞凋亡过程。此外,一个蛇鳞癌细胞系来自异种移植肿瘤模型用于进一步验证注射HOTAIR siRNA的抑制肿瘤生长。总之,我们建议,HOTAIR抑制可开发为在头颈部鳞癌治疗的新疗法。
关键词: HOTAIR
Current Molecular Medicine
Title:Targeting HOTAIR induces mitochondria related apoptosis and inhibits tumor growth in head and neck squamous cell carcinoma in vitro and in vivo.
Volume: 15 Issue: 10
Author(s): L. Kong, X. Zhou, Y. Wu, Y. Wang, L. Chen, P. Li, S. Liu, S. Sun, Y. Ren, M. Mei, X. Wang and L. Zhang
Affiliation:
关键词: HOTAIR
摘要: Homeobox (HOX) transcript antisense RNA (HOTAIR), a long nuclear-retained noncoding RNA (lncRNA), is overexpressed in a variety of human cancers. Increasing evidence shows that HOTAIR plays a vital role in cancer initiation and progression by affecting cell cycle progress, apoptosis and invasion. However, whether HOTAIR serves as a target of therapeutic potential and the underlying mechanism in head and neck squamous cell carcinoma (HNSCC) is still unclear. Thus, we employed a HOTAIR specific siRNA to deplete its expression in two human HNSCC cell lines, Tca8113 and Tscca. The flow cytometry (FCM) analysis showed that HOTAIR depletion induced tumor cell apoptosis in vitro. JC-1 probe examination showed that the mitochondrial membrane potential was changed significantly by HOTAIR blockage. Mitochondrial calcium uptake 1(MICU1) dependent cell death was induced by HOTAIR depletion. Protein expression analysis indicated that mitochondrial related cell death pathway (Bcl-2, BAX, Caspase-3, Cleaved Caspase-3, Cytochrome c) involved in HOTAIR dependent apoptosis process. Moreover, a Tscca derived xenograft tumor model was employed to further validate that injection of HOTAIR siRNA inhibited tumor growth. In summary, we suggested that HOTAIR inhibition could be developed as a new therapeutic in HNSCC treatments.
Export Options
About this article
Cite this article as:
L. Kong, X. Zhou, Y. Wu, Y. Wang, L. Chen, P. Li, S. Liu, S. Sun, Y. Ren, M. Mei, X. Wang and L. Zhang , Targeting HOTAIR induces mitochondria related apoptosis and inhibits tumor growth in head and neck squamous cell carcinoma in vitro and in vivo., Current Molecular Medicine 2015; 15 (10) . https://dx.doi.org/10.2174/1566524016666151123112716
DOI https://dx.doi.org/10.2174/1566524016666151123112716 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Near-infrared Light Activatable Multimodal Gold Nanostructures Platform: An Emerging Paradigm for Cancer Therapy
Current Cancer Drug Targets New Approaches to Target Cancer Stem Cells: Current Scenario
Mini-Reviews in Medicinal Chemistry Manipulation of Glycolysis in Malignant Tumors: Fantasy or Therapy?
Current Medicinal Chemistry Polo-Like Kinases Inhibitors
Current Medicinal Chemistry Peptides in Oral Diseases
Current Pharmaceutical Design Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
Current Gene Therapy Novel Drug Therapies for Fertility Preservation in Men Undergoing Chemotherapy: Clinical Relevance of Protector Agents
Current Medicinal Chemistry Celecoxib and Dimethylcelecoxib Block Oxidative Phosphorylation, Epithelial-Mesenchymal Transition and Invasiveness in Breast Cancer Stem Cells
Current Medicinal Chemistry Epigenetics and Periodontal Disease: Hope to Tame the Untameable
Current Gene Therapy Recent Patents of Gene Sequences Relative to the Phosphatidylinositol 3-kinase / Akt Pathway and their Relevance to Drug Discovery
Recent Patents on DNA & Gene Sequences Future Prospect of RNA Interference for Cancer Therapies
Current Drug Targets The Ovary Feels Fine when Paracrine and Autocrine Networks Cooperate with Gonadotropins in the Regulation of Folliculogenesis
Current Pharmaceutical Design Targeting Cancer Cells by an Oxidant-Based Therapy
Current Molecular Pharmacology Gain of Function Effects of Z Alpha-1 Antitrypsin
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Meet the Editorial Board:
Protein & Peptide Letters Anlotinib-Induced Hypertension: Current Concepts and Future Prospects
Current Pharmaceutical Design Anti-Tumor Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D Analogs
Current Pharmaceutical Design Anti-Cancer Potential of Some Commonly Used Drugs
Current Pharmaceutical Design The PI3K/Akt Pathway: Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors
Current Cancer Drug Targets Curcumin Targets Circulating Cancer Stem Cells by Inhibiting Self-Renewal Efficacy in Non-Small Cell Lung Carcinoma
Anti-Cancer Agents in Medicinal Chemistry